Fig. 6

Mean plasma F₂-isoprostane concentration at rest (pre), after 45 min cycling at 70% VO_2peak (45 min) and after the time trial (post), data are presented as mean ± SD (A), correlation between change in time to complete the time trial following MitoQ supplementation and plasma F₂-isoprostanes at rest following placebo supplementation (B), and correlation between change in time to complete the time trial following MitoQ supplementation and exercise-induced changes in plasma F₂-isoprostanes following placebo supplementation (C). Two-way repeated-measures ANOVA effects are given in figures and * p < 0.05 for post hoc vs placebo at the same time point, n = 16